

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 9.80469128 |
| 2 | sulfate transport (GO:0008272) | 8.41563525 |
| 3 | flavonoid metabolic process (GO:0009812) | 8.08225933 |
| 4 | positive regulation of respiratory burst (GO:0060267) | 7.93424635 |
| 5 | intestinal cholesterol absorption (GO:0030299) | 7.85234722 |
| 6 | angiotensin maturation (GO:0002003) | 6.75777665 |
| 7 | regulation of respiratory burst (GO:0060263) | 6.59565880 |
| 8 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 6.50127316 |
| 9 | oligosaccharide biosynthetic process (GO:0009312) | 6.43387299 |
| 10 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 6.34172387 |
| 11 | renal system process involved in regulation of blood volume (GO:0001977) | 6.06425562 |
| 12 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.99163864 |
| 13 | cellular ketone body metabolic process (GO:0046950) | 5.97706596 |
| 14 | glucocorticoid biosynthetic process (GO:0006704) | 5.96832221 |
| 15 | regulation of guanylate cyclase activity (GO:0031282) | 5.95877762 |
| 16 | ethanol oxidation (GO:0006069) | 5.86567181 |
| 17 | glomerular filtration (GO:0003094) | 5.81629426 |
| 18 | positive regulation of keratinocyte differentiation (GO:0045618) | 5.60216622 |
| 19 | one-carbon metabolic process (GO:0006730) | 5.56184231 |
| 20 | sulfation (GO:0051923) | 5.49022738 |
| 21 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.47420296 |
| 22 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.47420296 |
| 23 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.36901143 |
| 24 | actin filament depolymerization (GO:0030042) | 5.34213683 |
| 25 | vitamin A metabolic process (GO:0006776) | 5.31823125 |
| 26 | renal filtration (GO:0097205) | 5.30763328 |
| 27 | regulation of intracellular pH (GO:0051453) | 5.30731939 |
| 28 | positive regulation of epidermal cell differentiation (GO:0045606) | 5.14560773 |
| 29 | ketone body metabolic process (GO:1902224) | 5.13787628 |
| 30 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 5.13420402 |
| 31 | positive regulation of fatty acid oxidation (GO:0046321) | 4.95170780 |
| 32 | regulation of bile acid biosynthetic process (GO:0070857) | 4.91211067 |
| 33 | regulation of cellular pH (GO:0030641) | 4.88845439 |
| 34 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.84667967 |
| 35 | antibacterial humoral response (GO:0019731) | 4.84163463 |
| 36 | digestive system process (GO:0022600) | 4.83576684 |
| 37 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.76386134 |
| 38 | antimicrobial humoral response (GO:0019730) | 4.73754674 |
| 39 | negative regulation of myotube differentiation (GO:0010832) | 4.66716426 |
| 40 | ethanol metabolic process (GO:0006067) | 4.61311132 |
| 41 | intestinal epithelial cell development (GO:0060576) | 4.61210522 |
| 42 | desmosome organization (GO:0002934) | 4.59707720 |
| 43 | positive regulation of pseudopodium assembly (GO:0031274) | 4.50486721 |
| 44 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.49205311 |
| 45 | sulfur compound transport (GO:0072348) | 4.33317560 |
| 46 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 4.29916224 |
| 47 | labyrinthine layer development (GO:0060711) | 4.29296080 |
| 48 | drug catabolic process (GO:0042737) | 4.21350838 |
| 49 | regulation of pH (GO:0006885) | 4.14394961 |
| 50 | positive regulation of systemic arterial blood pressure (GO:0003084) | 4.14294430 |
| 51 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.11696215 |
| 52 | ATP synthesis coupled proton transport (GO:0015986) | 4.11696215 |
| 53 | cellular response to pH (GO:0071467) | 4.07598782 |
| 54 | response to hepatocyte growth factor (GO:0035728) | 4.06509594 |
| 55 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.06509594 |
| 56 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.06180646 |
| 57 | regulation of pseudopodium assembly (GO:0031272) | 4.03609195 |
| 58 | adhesion of symbiont to host cell (GO:0044650) | 3.95435637 |
| 59 | virion attachment to host cell (GO:0019062) | 3.95435637 |
| 60 | regulation of triglyceride catabolic process (GO:0010896) | 3.95346357 |
| 61 | cGMP-mediated signaling (GO:0019934) | 3.93804601 |
| 62 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.90103732 |
| 63 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.90103732 |
| 64 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.90103732 |
| 65 | transcytosis (GO:0045056) | 3.89926844 |
| 66 | sperm capacitation (GO:0048240) | 3.88389408 |
| 67 | glucose 6-phosphate metabolic process (GO:0051156) | 3.83203346 |
| 68 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.82770848 |
| 69 | O-glycan processing (GO:0016266) | 3.80358328 |
| 70 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.77884756 |
| 71 | cellular monovalent inorganic cation homeostasis (GO:0030004) | 3.75601161 |
| 72 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.74927390 |
| 73 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.70862703 |
| 74 | epithelial structure maintenance (GO:0010669) | 3.69465474 |
| 75 | transepithelial transport (GO:0070633) | 3.63554417 |
| 76 | thrombin receptor signaling pathway (GO:0070493) | 3.63247106 |
| 77 | bicarbonate transport (GO:0015701) | 3.62826820 |
| 78 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.62454173 |
| 79 | response to acidic pH (GO:0010447) | 3.59953042 |
| 80 | monovalent inorganic cation homeostasis (GO:0055067) | 3.58718168 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.58029111 |
| 82 | hepatocyte apoptotic process (GO:0097284) | 3.57613604 |
| 83 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.57480196 |
| 84 | fructose metabolic process (GO:0006000) | 3.56984006 |
| 85 | regulation of cGMP biosynthetic process (GO:0030826) | 3.56024470 |
| 86 | bile acid and bile salt transport (GO:0015721) | 3.55513398 |
| 87 | excretion (GO:0007588) | 3.53138667 |
| 88 | cellular glucuronidation (GO:0052695) | 3.52623264 |
| 89 | regulation of systemic arterial blood pressure (GO:0003073) | 3.50450305 |
| 90 | innate immune response in mucosa (GO:0002227) | 3.50371908 |
| 91 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.47862173 |
| 92 | phospholipid efflux (GO:0033700) | 3.46675416 |
| 93 | hormone catabolic process (GO:0042447) | 3.46463986 |
| 94 | digestion (GO:0007586) | 3.46287199 |
| 95 | intermediate filament organization (GO:0045109) | 3.45106703 |
| 96 | viral transcription (GO:0019083) | 3.43299658 |
| 97 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.42789848 |
| 98 | cellular response to cAMP (GO:0071320) | 3.42414719 |
| 99 | sodium ion homeostasis (GO:0055078) | 3.42286904 |
| 100 | protein-lipid complex assembly (GO:0065005) | 3.41314781 |
| 101 | response to food (GO:0032094) | 3.40042335 |
| 102 | thyroid hormone metabolic process (GO:0042403) | 3.39235387 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.36834687 |
| 104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.36196175 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.36196175 |
| 106 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.34988735 |
| 107 | positive regulation of epidermis development (GO:0045684) | 3.33601867 |
| 108 | glucocorticoid metabolic process (GO:0008211) | 3.33462974 |
| 109 | sterol homeostasis (GO:0055092) | 3.33283862 |
| 110 | inner mitochondrial membrane organization (GO:0007007) | 3.31525447 |
| 111 | regulation of viral release from host cell (GO:1902186) | 3.31163375 |
| 112 | regulation of cholesterol esterification (GO:0010872) | 3.30308952 |
| 113 | drug transmembrane transport (GO:0006855) | 3.29487510 |
| 114 | defense response to fungus (GO:0050832) | 3.28018645 |
| 115 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.26915395 |
| 116 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.25295484 |
| 117 | fucosylation (GO:0036065) | 3.25031878 |
| 118 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.24519139 |
| 119 | positive regulation of response to oxidative stress (GO:1902884) | 3.24519139 |
| 120 | regulation of actin nucleation (GO:0051125) | 3.24488020 |
| 121 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.24239734 |
| 122 | translational termination (GO:0006415) | 3.23667659 |
| 123 | glucuronate metabolic process (GO:0019585) | 3.22977744 |
| 124 | uronic acid metabolic process (GO:0006063) | 3.22977744 |
| 125 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.22256849 |
| 126 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.19970973 |
| 127 | regulation of chemokine secretion (GO:0090196) | 3.19095964 |
| 128 | killing of cells of other organism (GO:0031640) | 3.19074966 |
| 129 | disruption of cells of other organism (GO:0044364) | 3.19074966 |
| 130 | regulation of vitamin metabolic process (GO:0030656) | 3.17194632 |
| 131 | lipoprotein metabolic process (GO:0042157) | 3.15905363 |
| 132 | GDP-mannose metabolic process (GO:0019673) | 3.15809690 |
| 133 | sulfate transmembrane transport (GO:1902358) | 3.14397944 |
| 134 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.14395013 |
| 135 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.14258629 |
| 136 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.13285119 |
| 137 | phenylpropanoid metabolic process (GO:0009698) | 3.12077975 |
| 138 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.10644730 |
| 139 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.10644730 |
| 140 | endocrine process (GO:0050886) | 3.10644730 |
| 141 | sulfur amino acid catabolic process (GO:0000098) | 3.08698947 |
| 142 | gap junction assembly (GO:0016264) | 3.07773382 |
| 143 | receptor recycling (GO:0001881) | 3.07209966 |
| 144 | regulation of keratinocyte differentiation (GO:0045616) | 3.05889052 |
| 145 | NADH metabolic process (GO:0006734) | 3.05135559 |
| 146 | ATP biosynthetic process (GO:0006754) | 3.05066774 |
| 147 | auditory receptor cell differentiation (GO:0042491) | 3.04437936 |
| 148 | positive regulation of lipid catabolic process (GO:0050996) | 3.03721399 |
| 149 | nucleotide-sugar metabolic process (GO:0009225) | 3.02987379 |
| 150 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.00798122 |
| 151 | primary alcohol catabolic process (GO:0034310) | 3.00538112 |
| 152 | hemidesmosome assembly (GO:0031581) | 3.00375480 |
| 153 | response to nitrosative stress (GO:0051409) | 2.98801632 |
| 154 | lipoprotein transport (GO:0042953) | 2.97894122 |
| 155 | regulation of cholesterol homeostasis (GO:2000188) | 2.97680829 |
| 156 | respiratory electron transport chain (GO:0022904) | 2.95862676 |
| 157 | adhesion of symbiont to host (GO:0044406) | 2.95737769 |
| 158 | membrane hyperpolarization (GO:0060081) | 2.93367221 |
| 159 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.90815543 |
| 160 | regulation of cGMP metabolic process (GO:0030823) | 2.88314359 |
| 161 | inorganic anion transmembrane transport (GO:0098661) | 2.87249759 |
| 162 | electron transport chain (GO:0022900) | 2.87030201 |
| 163 | trophectodermal cell differentiation (GO:0001829) | 2.86880779 |
| 164 | membrane repolarization during action potential (GO:0086011) | 2.86259022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.45009560 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 6.56700011 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 4.42577414 |
| 4 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 4.02324147 |
| 5 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.54936361 |
| 6 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.48454330 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.44804833 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.36697796 |
| 9 | SOX2_20726797_ChIP-Seq_SW620_Human | 3.04756898 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.96219565 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.90625709 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.87807639 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.51243724 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48472101 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.30652566 |
| 16 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.29316246 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.18178848 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.14148266 |
| 19 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.12606662 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.10674443 |
| 21 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.04160373 |
| 22 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.98899620 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.98767913 |
| 24 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.95677653 |
| 25 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.85126939 |
| 26 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.83864721 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83774659 |
| 28 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.77748447 |
| 29 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.75201941 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74992981 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.73748771 |
| 32 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.72218990 |
| 33 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.70310136 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.68501200 |
| 35 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67692789 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.66848036 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66822391 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64429630 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.63096020 |
| 40 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.58708952 |
| 41 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.58443757 |
| 42 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.52478325 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49777565 |
| 44 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.46372471 |
| 45 | ATF3_27146783_Chip-Seq_COLON_Human | 1.45267486 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.44700826 |
| 47 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.43087280 |
| 48 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.40425280 |
| 49 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40395161 |
| 50 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.39512704 |
| 51 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.39468732 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38477382 |
| 53 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38302550 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36186832 |
| 55 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35541607 |
| 56 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34988733 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34045042 |
| 58 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33262660 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33117450 |
| 60 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.31068130 |
| 61 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.26826924 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22345169 |
| 63 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.21441039 |
| 64 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21016966 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18168861 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15342270 |
| 67 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15194357 |
| 68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15194357 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13833029 |
| 70 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12304682 |
| 71 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.12028875 |
| 72 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11709772 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11497163 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10051580 |
| 75 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09677169 |
| 76 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09410872 |
| 77 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.08527653 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08396872 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07032193 |
| 80 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.06632479 |
| 81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06247690 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05407796 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02249921 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00234464 |
| 85 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.99872050 |
| 86 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98873523 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98221893 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98053373 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96771082 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96641132 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96008451 |
| 92 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.94926490 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94809685 |
| 94 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.94799302 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94388871 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 0.91540889 |
| 97 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.90579135 |
| 98 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90579135 |
| 99 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.90579135 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89682926 |
| 101 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.88747858 |
| 102 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88236667 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87712304 |
| 104 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87313890 |
| 105 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86988623 |
| 106 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86735316 |
| 107 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86237129 |
| 108 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85802949 |
| 109 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.85446612 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85038844 |
| 111 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.84681946 |
| 112 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.84039844 |
| 113 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.83886558 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83492613 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83025657 |
| 116 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.83016697 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82157878 |
| 118 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81978134 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81545070 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.81512997 |
| 121 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81313986 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79948046 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79751825 |
| 124 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.79485872 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78062815 |
| 126 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77531686 |
| 127 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77316639 |
| 128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.76842894 |
| 129 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74320951 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72719991 |
| 131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72029052 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.71001494 |
| 133 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.70851074 |
| 134 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.70107049 |
| 135 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.69985885 |
| 136 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.69730515 |
| 137 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.68994284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.75198061 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.15782729 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.80204801 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 4.05214870 |
| 5 | MP0000462_abnormal_digestive_system | 4.05148513 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.67393502 |
| 7 | MP0003866_abnormal_defecation | 3.58769080 |
| 8 | MP0009379_abnormal_foot_pigmentation | 3.31913026 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.04685892 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.84788139 |
| 11 | MP0001663_abnormal_digestive_system | 2.71862501 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.63328057 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.62139629 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.60580928 |
| 15 | MP0005381_digestive/alimentary_phenotyp | 2.58390970 |
| 16 | MP0009840_abnormal_foam_cell | 2.57297601 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.38980761 |
| 18 | MP0000490_abnormal_crypts_of | 2.35161360 |
| 19 | MP0003283_abnormal_digestive_organ | 2.32086181 |
| 20 | MP0001664_abnormal_digestion | 2.17328031 |
| 21 | MP0003252_abnormal_bile_duct | 2.17239447 |
| 22 | MP0000477_abnormal_intestine_morphology | 2.14478740 |
| 23 | MP0010329_abnormal_lipoprotein_level | 2.08292729 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 2.01587307 |
| 25 | MP0001873_stomach_inflammation | 2.00109995 |
| 26 | MP0000537_abnormal_urethra_morphology | 1.96062403 |
| 27 | MP0005670_abnormal_white_adipose | 1.88298426 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.86836589 |
| 29 | MP0002822_catalepsy | 1.82075152 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.78606191 |
| 31 | MP0005365_abnormal_bile_salt | 1.76229167 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.66870143 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 1.60076156 |
| 34 | MP0006054_spinal_hemorrhage | 1.57443747 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.46283876 |
| 36 | MP0002796_impaired_skin_barrier | 1.46003126 |
| 37 | MP0004147_increased_porphyrin_level | 1.45735634 |
| 38 | MP0008004_abnormal_stomach_pH | 1.44327655 |
| 39 | MP0003724_increased_susceptibility_to | 1.44252532 |
| 40 | MP0008872_abnormal_physiological_respon | 1.42618991 |
| 41 | MP0005409_darkened_coat_color | 1.39387456 |
| 42 | MP0004043_abnormal_pH_regulation | 1.39096628 |
| 43 | MP0003303_peritoneal_inflammation | 1.38253137 |
| 44 | MP0001849_ear_inflammation | 1.37124539 |
| 45 | MP0001765_abnormal_ion_homeostasis | 1.33781613 |
| 46 | MP0000230_abnormal_systemic_arterial | 1.31717196 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.25968981 |
| 48 | MP0005377_hearing/vestibular/ear_phenot | 1.25545517 |
| 49 | MP0003878_abnormal_ear_physiology | 1.25545517 |
| 50 | MP0002132_abnormal_respiratory_system | 1.24569171 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.18678822 |
| 52 | MP0005448_abnormal_energy_balance | 1.15946771 |
| 53 | MP0003567_abnormal_fetal_cardiomyocyte | 1.13934003 |
| 54 | MP0004947_skin_inflammation | 1.11988648 |
| 55 | MP0000467_abnormal_esophagus_morphology | 1.11409182 |
| 56 | MP0002006_tumorigenesis | 1.10960649 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.10135516 |
| 58 | MP0005166_decreased_susceptibility_to | 1.09671211 |
| 59 | MP0002089_abnormal_postnatal_growth/wei | 1.08954547 |
| 60 | MP0005451_abnormal_body_composition | 1.02336751 |
| 61 | MP0003693_abnormal_embryo_hatching | 1.02078864 |
| 62 | MP0000566_synostosis | 1.00570043 |
| 63 | MP0002163_abnormal_gland_morphology | 1.00570000 |
| 64 | MP0005332_abnormal_amino_acid | 0.98858729 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 0.95563934 |
| 66 | MP0001188_hyperpigmentation | 0.95000445 |
| 67 | MP0010678_abnormal_skin_adnexa | 0.93609621 |
| 68 | MP0009785_altered_susceptibility_to | 0.92129466 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 0.90299096 |
| 70 | MP0000470_abnormal_stomach_morphology | 0.89818830 |
| 71 | MP0005165_increased_susceptibility_to | 0.89780895 |
| 72 | MP0009780_abnormal_chondrocyte_physiolo | 0.89364875 |
| 73 | MP0001764_abnormal_homeostasis | 0.88626417 |
| 74 | MP0009697_abnormal_copulation | 0.88299288 |
| 75 | MP0003868_abnormal_feces_composition | 0.86238813 |
| 76 | MP0001727_abnormal_embryo_implantation | 0.82507200 |
| 77 | MP0004957_abnormal_blastocyst_morpholog | 0.81791515 |
| 78 | MP0006082_CNS_inflammation | 0.81659639 |
| 79 | MP0002009_preneoplasia | 0.81230852 |
| 80 | MP0005666_abnormal_adipose_tissue | 0.80521590 |
| 81 | MP0004270_analgesia | 0.78860990 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.78493316 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.77741613 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.77740602 |
| 85 | MP0000609_abnormal_liver_physiology | 0.77454006 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 0.77442935 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 0.76680213 |
| 88 | MP0005501_abnormal_skin_physiology | 0.76084991 |
| 89 | MP0005266_abnormal_metabolism | 0.74794036 |
| 90 | MP0005187_abnormal_penis_morphology | 0.74309427 |
| 91 | MP0005257_abnormal_intraocular_pressure | 0.74120061 |
| 92 | MP0003718_maternal_effect | 0.74019386 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.72753154 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.72110189 |
| 95 | MP0002896_abnormal_bone_mineralization | 0.70725959 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.70360631 |
| 97 | MP0001756_abnormal_urination | 0.70150223 |
| 98 | MP0004484_altered_response_of | 0.69473593 |
| 99 | MP0009384_cardiac_valve_regurgitation | 0.69011408 |
| 100 | MP0003315_abnormal_perineum_morphology | 0.68923921 |
| 101 | MP0000377_abnormal_hair_follicle | 0.67686667 |
| 102 | MP0005025_abnormal_response_to | 0.66741620 |
| 103 | MP0002254_reproductive_system_inflammat | 0.66281428 |
| 104 | MP0009053_abnormal_anal_canal | 0.65953462 |
| 105 | MP0009333_abnormal_splenocyte_physiolog | 0.65110796 |
| 106 | MP0000613_abnormal_salivary_gland | 0.65063527 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.64565024 |
| 108 | MP0002060_abnormal_skin_morphology | 0.63472155 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.63179592 |
| 110 | MP0001216_abnormal_epidermal_layer | 0.58824010 |
| 111 | MP0005023_abnormal_wound_healing | 0.58720678 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.55540613 |
| 113 | MP0002932_abnormal_joint_morphology | 0.54871197 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.54595805 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.53936510 |
| 116 | MP0005408_hypopigmentation | 0.53492980 |
| 117 | MP0002166_altered_tumor_susceptibility | 0.52646213 |
| 118 | MP0005595_abnormal_vascular_smooth | 0.52000018 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.51320013 |
| 120 | MP0002148_abnormal_hypersensitivity_rea | 0.51174479 |
| 121 | MP0008873_increased_physiological_sensi | 0.51029163 |
| 122 | MP0002971_abnormal_brown_adipose | 0.50625015 |
| 123 | MP0001845_abnormal_inflammatory_respons | 0.50160727 |
| 124 | MP0003045_fibrosis | 0.50030281 |
| 125 | MP0005310_abnormal_salivary_gland | 0.49899334 |
| 126 | MP0005174_abnormal_tail_pigmentation | 0.49339724 |
| 127 | MP0003879_abnormal_hair_cell | 0.47892529 |
| 128 | MP0003953_abnormal_hormone_level | 0.47619382 |
| 129 | MP0000678_abnormal_parathyroid_gland | 0.46236801 |
| 130 | MP0000762_abnormal_tongue_morphology | 0.45654104 |
| 131 | MP0010307_abnormal_tumor_latency | 0.45454191 |
| 132 | MP0009115_abnormal_fat_cell | 0.45145916 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.43784925 |
| 134 | MP0001533_abnormal_skeleton_physiology | 0.42178773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperaldosteronism (HP:0000859) | 6.16309503 |
| 2 | Hyponatremia (HP:0002902) | 5.21323167 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 5.19937104 |
| 4 | Neonatal short-limb short stature (HP:0008921) | 5.15857064 |
| 5 | Flat capital femoral epiphysis (HP:0003370) | 4.85955544 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.72829540 |
| 7 | Flattened epiphyses (HP:0003071) | 4.65261206 |
| 8 | Hypokalemia (HP:0002900) | 4.49796351 |
| 9 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 4.39203313 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.34294520 |
| 11 | Malnutrition (HP:0004395) | 4.32842846 |
| 12 | Ventricular fibrillation (HP:0001663) | 4.24461902 |
| 13 | Conjugated hyperbilirubinemia (HP:0002908) | 4.18172376 |
| 14 | Acanthocytosis (HP:0001927) | 4.17241848 |
| 15 | Abnormality of potassium homeostasis (HP:0011042) | 4.13599064 |
| 16 | Rectal prolapse (HP:0002035) | 4.05825224 |
| 17 | Abnormality of sodium homeostasis (HP:0010931) | 3.94638130 |
| 18 | Spinal cord compression (HP:0002176) | 3.80759507 |
| 19 | Breech presentation (HP:0001623) | 3.73676900 |
| 20 | Visceral angiomatosis (HP:0100761) | 3.65804371 |
| 21 | Abdominal distention (HP:0003270) | 3.65053050 |
| 22 | Hyperkalemia (HP:0002153) | 3.63457951 |
| 23 | Fat malabsorption (HP:0002630) | 3.62447184 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 3.58228246 |
| 25 | Gastrointestinal dysmotility (HP:0002579) | 3.57084861 |
| 26 | Metabolic alkalosis (HP:0200114) | 3.48192190 |
| 27 | Increased muscle lipid content (HP:0009058) | 3.42918674 |
| 28 | Abnormal biliary tract morphology (HP:0012440) | 3.41491098 |
| 29 | Abnormality of urine glucose concentration (HP:0011016) | 3.37699138 |
| 30 | Glycosuria (HP:0003076) | 3.37699138 |
| 31 | Chronic diarrhea (HP:0002028) | 3.36577026 |
| 32 | Hemangiomatosis (HP:0007461) | 3.35314608 |
| 33 | Hydroxyprolinuria (HP:0003080) | 3.35008854 |
| 34 | Abnormality of proline metabolism (HP:0010907) | 3.35008854 |
| 35 | Vertebral hypoplasia (HP:0008417) | 3.32584115 |
| 36 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.32584115 |
| 37 | Increased intramyocellular lipid droplets (HP:0012240) | 3.29457435 |
| 38 | Adrenal overactivity (HP:0002717) | 3.29070498 |
| 39 | Abnormal tarsal ossification (HP:0008369) | 3.24187321 |
| 40 | Irregular epiphyses (HP:0010582) | 3.22873531 |
| 41 | Vertebral clefting (HP:0008428) | 3.21785278 |
| 42 | Large earlobe (HP:0009748) | 3.17637619 |
| 43 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.16901717 |
| 44 | Congenital sensorineural hearing impairment (HP:0008527) | 3.12846771 |
| 45 | Cupped ribs (HP:0000887) | 3.08087457 |
| 46 | Widely patent fontanelles and sutures (HP:0004492) | 3.03391731 |
| 47 | Abnormal cartilage morphology (HP:0002763) | 3.02881807 |
| 48 | Abnormal vertebral ossification (HP:0100569) | 3.02650916 |
| 49 | Intrahepatic cholestasis (HP:0001406) | 2.99751216 |
| 50 | Abnormal hemoglobin (HP:0011902) | 2.95382278 |
| 51 | Hemorrhage of the eye (HP:0011885) | 2.94833511 |
| 52 | Woolly hair (HP:0002224) | 2.92507520 |
| 53 | Dehydration (HP:0001944) | 2.91262849 |
| 54 | Villous atrophy (HP:0011473) | 2.87578631 |
| 55 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.87578631 |
| 56 | Pustule (HP:0200039) | 2.85767432 |
| 57 | Decreased circulating renin level (HP:0003351) | 2.78546272 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.72401446 |
| 59 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.71149384 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.65373205 |
| 61 | Progressive sensorineural hearing impairment (HP:0000408) | 2.62798101 |
| 62 | Abnormality of chloride homeostasis (HP:0011422) | 2.59987882 |
| 63 | Biliary tract neoplasm (HP:0100574) | 2.58512274 |
| 64 | Hyperactive renin-angiotensin system (HP:0000841) | 2.58110375 |
| 65 | Abnormality of the 1st metacarpal (HP:0010009) | 2.57285201 |
| 66 | Male infertility (HP:0003251) | 2.57162701 |
| 67 | Micronodular cirrhosis (HP:0001413) | 2.56124472 |
| 68 | Palpitations (HP:0001962) | 2.54488641 |
| 69 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.52996733 |
| 70 | Lipid accumulation in hepatocytes (HP:0006561) | 2.52461990 |
| 71 | Abnormality of carpal bone ossification (HP:0006257) | 2.49832809 |
| 72 | Pigmentary retinal degeneration (HP:0001146) | 2.47302120 |
| 73 | Syncope (HP:0001279) | 2.44266681 |
| 74 | Macrocytic anemia (HP:0001972) | 2.43536550 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.38610412 |
| 76 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.37748131 |
| 77 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.35806156 |
| 78 | Sensory axonal neuropathy (HP:0003390) | 2.35519881 |
| 79 | Cheilitis (HP:0100825) | 2.35426700 |
| 80 | Abnormality of vitamin B metabolism (HP:0004340) | 2.34938904 |
| 81 | Hypolipoproteinemia (HP:0010981) | 2.33369803 |
| 82 | Hyperphosphaturia (HP:0003109) | 2.31817931 |
| 83 | Wide cranial sutures (HP:0010537) | 2.31221846 |
| 84 | Hoarse voice (HP:0001609) | 2.29543745 |
| 85 | Abnormality of the gastric mucosa (HP:0004295) | 2.29190146 |
| 86 | Milia (HP:0001056) | 2.29185521 |
| 87 | Hyperglycinuria (HP:0003108) | 2.28661506 |
| 88 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.28213427 |
| 89 | Short middle phalanx of finger (HP:0005819) | 2.27230414 |
| 90 | Abnormal hair laboratory examination (HP:0003328) | 2.24788063 |
| 91 | Increased hepatocellular lipid droplets (HP:0006565) | 2.23799522 |
| 92 | Abnormality of renin-angiotensin system (HP:0000847) | 2.17629280 |
| 93 | Hip contracture (HP:0003273) | 2.17527124 |
| 94 | Ventricular arrhythmia (HP:0004308) | 2.15996540 |
| 95 | Progressive hearing impairment (HP:0001730) | 2.14982407 |
| 96 | Conjunctival hamartoma (HP:0100780) | 2.14929995 |
| 97 | Abnormal foot bone ossification (HP:0010675) | 2.14507396 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13281600 |
| 99 | Poikilocytosis (HP:0004447) | 2.12249484 |
| 100 | Chronic bronchitis (HP:0004469) | 2.09633736 |
| 101 | Abnormal urine phosphate concentration (HP:0012599) | 2.09441265 |
| 102 | Pili torti (HP:0003777) | 2.05408947 |
| 103 | Subacute progressive viral hepatitis (HP:0006572) | 2.04265350 |
| 104 | Hyperparathyroidism (HP:0000843) | 2.03476720 |
| 105 | Abnormality of vitamin metabolism (HP:0100508) | 2.02596242 |
| 106 | Symptomatic seizures (HP:0011145) | 2.02060818 |
| 107 | Nausea (HP:0002018) | 2.01215275 |
| 108 | Alkalosis (HP:0001948) | 2.00525151 |
| 109 | Premature loss of primary teeth (HP:0006323) | 2.00380834 |
| 110 | Fragile skin (HP:0001030) | 2.00290711 |
| 111 | Goiter (HP:0000853) | 2.00275526 |
| 112 | Renal tubular acidosis (HP:0001947) | 2.00033494 |
| 113 | Ileus (HP:0002595) | 10.1922013 |
| 114 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99518790 |
| 115 | Onycholysis (HP:0001806) | 1.97849642 |
| 116 | Hyperammonemia (HP:0001987) | 1.97691504 |
| 117 | Neoplasm of the rectum (HP:0100743) | 1.97114065 |
| 118 | Increased density of long bones (HP:0006392) | 1.93901933 |
| 119 | Fragile nails (HP:0001808) | 1.93428120 |
| 120 | Flat acetabular roof (HP:0003180) | 1.93157081 |
| 121 | Facial shape deformation (HP:0011334) | 1.92972246 |
| 122 | Potter facies (HP:0002009) | 1.92972246 |
| 123 | Thin bony cortex (HP:0002753) | 1.92448307 |
| 124 | Abnormal hand bone ossification (HP:0010660) | 1.92235721 |
| 125 | Stillbirth (HP:0003826) | 1.91131527 |
| 126 | Increased mean platelet volume (HP:0011877) | 1.90989224 |
| 127 | Hip dysplasia (HP:0001385) | 1.90431376 |
| 128 | Plantar hyperkeratosis (HP:0007556) | 1.90099254 |
| 129 | Polygenic inheritance (HP:0010982) | 1.89733490 |
| 130 | Hypoglycemic coma (HP:0001325) | 1.89711491 |
| 131 | Abnormal ossification of hand bones (HP:0005921) | 1.88678945 |
| 132 | Short phalanx of the thumb (HP:0009660) | 1.88356813 |
| 133 | Petechiae (HP:0000967) | 1.88298272 |
| 134 | Bone cyst (HP:0012062) | 1.87482870 |
| 135 | Proximal tubulopathy (HP:0000114) | 1.85389268 |
| 136 | Neoplasm of the small intestine (HP:0100833) | 1.82559568 |
| 137 | Hepatic necrosis (HP:0002605) | 1.80687738 |
| 138 | Sensorimotor neuropathy (HP:0007141) | 1.80230645 |
| 139 | Abnormality of the right ventricle (HP:0001707) | 1.80045336 |
| 140 | Nonimmune hydrops fetalis (HP:0001790) | 1.79836218 |
| 141 | Ankyloglossia (HP:0010296) | 1.79747975 |
| 142 | Abnormality of B cell number (HP:0010975) | 1.79078005 |
| 143 | B lymphocytopenia (HP:0010976) | 1.79078005 |
| 144 | Dicarboxylic aciduria (HP:0003215) | 1.78214065 |
| 145 | Abnormality of the acetabulum (HP:0003170) | 1.77487884 |
| 146 | Renal salt wasting (HP:0000127) | 1.73356296 |
| 147 | Curly hair (HP:0002212) | 1.72373781 |
| 148 | Severe short stature (HP:0003510) | 1.72238748 |
| 149 | Bundle branch block (HP:0011710) | 1.71485975 |
| 150 | Cerebral hemorrhage (HP:0001342) | 1.68379384 |
| 151 | Hypotension (HP:0002615) | 1.63738935 |
| 152 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.62168301 |
| 153 | Cone-rod dystrophy (HP:0000548) | 1.60379654 |
| 154 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.60225635 |
| 155 | Late onset (HP:0003584) | 1.58705988 |
| 156 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 1.58206517 |
| 157 | Eczematoid dermatitis (HP:0000976) | 1.56466535 |
| 158 | Deviation of the thumb (HP:0009603) | 1.53783233 |
| 159 | Proximal placement of thumb (HP:0009623) | 1.53072306 |
| 160 | Tracheal stenosis (HP:0002777) | 1.48735112 |
| 161 | Protuberant abdomen (HP:0001538) | 1.47061711 |
| 162 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.46487753 |
| 163 | Abnormality of magnesium homeostasis (HP:0004921) | 1.44233189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 8.11538767 |
| 2 | FRK | 6.73658916 |
| 3 | ACVR1B | 5.84087405 |
| 4 | MST1R | 4.34126968 |
| 5 | PRKG2 | 3.62187744 |
| 6 | MST4 | 3.31529840 |
| 7 | NUAK1 | 2.95325654 |
| 8 | NME1 | 2.73279695 |
| 9 | MAP2K6 | 2.65924384 |
| 10 | MAP2K2 | 2.30622133 |
| 11 | MAP3K2 | 1.97512856 |
| 12 | TESK1 | 1.87902516 |
| 13 | EPHA2 | 1.72880596 |
| 14 | STK24 | 1.65969431 |
| 15 | ERN1 | 1.62696681 |
| 16 | GRK6 | 1.54537090 |
| 17 | TESK2 | 1.53268955 |
| 18 | STK39 | 1.53129554 |
| 19 | KSR2 | 1.46216067 |
| 20 | PTK6 | 1.45914430 |
| 21 | MET | 1.45885469 |
| 22 | RIPK1 | 1.43910191 |
| 23 | EPHB2 | 1.38638188 |
| 24 | PBK | 1.31452335 |
| 25 | PIK3CA | 1.25518837 |
| 26 | PDK2 | 1.25202251 |
| 27 | MAP3K10 | 1.21049895 |
| 28 | ERBB2 | 1.19500461 |
| 29 | TTK | 1.17091717 |
| 30 | MYLK | 1.05854555 |
| 31 | AKT3 | 1.01011846 |
| 32 | STK16 | 0.99873113 |
| 33 | PRKCI | 0.90660624 |
| 34 | PDPK1 | 0.90580315 |
| 35 | MUSK | 0.89412375 |
| 36 | PRPF4B | 0.80572103 |
| 37 | STK10 | 0.78685681 |
| 38 | TBK1 | 0.77679226 |
| 39 | ARAF | 0.76434878 |
| 40 | TAOK3 | 0.75010174 |
| 41 | LATS1 | 0.74421158 |
| 42 | MAP3K12 | 0.72466838 |
| 43 | MAP2K1 | 0.72117224 |
| 44 | PAK4 | 0.70020742 |
| 45 | MAP3K8 | 0.68783619 |
| 46 | WNK4 | 0.67857042 |
| 47 | MAP3K11 | 0.67647741 |
| 48 | AURKB | 0.67048639 |
| 49 | FER | 0.65833157 |
| 50 | PRKAA2 | 0.64988893 |
| 51 | MAP3K7 | 0.64233411 |
| 52 | MAPKAPK3 | 0.63307336 |
| 53 | SCYL2 | 0.62798048 |
| 54 | PDK1 | 0.61708120 |
| 55 | PAK3 | 0.61600589 |
| 56 | CDK19 | 0.60475132 |
| 57 | DMPK | 0.60381405 |
| 58 | BMX | 0.59364838 |
| 59 | PTK2 | 0.57936243 |
| 60 | MATK | 0.57073801 |
| 61 | SMG1 | 0.56533546 |
| 62 | EPHB1 | 0.56270359 |
| 63 | OXSR1 | 0.54661143 |
| 64 | MAP3K1 | 0.54652806 |
| 65 | PIM2 | 0.54395633 |
| 66 | NEK1 | 0.54300831 |
| 67 | DYRK1B | 0.52028970 |
| 68 | DDR2 | 0.50981981 |
| 69 | NME2 | 0.50157282 |
| 70 | TAOK1 | 0.49054248 |
| 71 | IRAK3 | 0.48283807 |
| 72 | MAP3K9 | 0.44944796 |
| 73 | TYK2 | 0.44471010 |
| 74 | LIMK1 | 0.42543671 |
| 75 | TNIK | 0.42339236 |
| 76 | CSNK1A1 | 0.41601296 |
| 77 | MAPKAPK2 | 0.40656856 |
| 78 | PRKCA | 0.40386257 |
| 79 | FGFR4 | 0.39280283 |
| 80 | LRRK2 | 0.38873068 |
| 81 | EPHA4 | 0.38784429 |
| 82 | CAMK2G | 0.37202442 |
| 83 | IKBKE | 0.36400534 |
| 84 | CAMK2D | 0.36219420 |
| 85 | GRK1 | 0.36163617 |
| 86 | PRKAA1 | 0.35602631 |
| 87 | CDK12 | 0.34537290 |
| 88 | CDC42BPA | 0.33992287 |
| 89 | PAK1 | 0.33492366 |
| 90 | PDK4 | 0.30869736 |
| 91 | PDK3 | 0.30869736 |
| 92 | NEK9 | 0.30793643 |
| 93 | RPS6KA2 | 0.29930232 |
| 94 | TRIB3 | 0.29370671 |
| 95 | RIPK4 | 0.29349790 |
| 96 | ROCK1 | 0.28123652 |
| 97 | SRC | 0.27673333 |
| 98 | RPS6KA1 | 0.26561828 |
| 99 | YES1 | 0.25940452 |
| 100 | CCNB1 | 0.25248839 |
| 101 | FGFR3 | 0.24925624 |
| 102 | CAMK2B | 0.24734743 |
| 103 | MAPK11 | 0.24425373 |
| 104 | ABL2 | 0.24166248 |
| 105 | PHKG1 | 0.24054792 |
| 106 | PHKG2 | 0.24054792 |
| 107 | PKN2 | 0.22197882 |
| 108 | MAPK15 | 0.21794483 |
| 109 | RET | 0.21581867 |
| 110 | WNK1 | 0.21471546 |
| 111 | MAP3K14 | 0.20571227 |
| 112 | CAMKK1 | 0.20431192 |
| 113 | PRKCQ | 0.20240955 |
| 114 | AKT2 | 0.20127077 |
| 115 | EPHA3 | 0.19630816 |
| 116 | CSK | 0.18943360 |
| 117 | NLK | 0.18889788 |
| 118 | MAP3K3 | 0.18646902 |
| 119 | LYN | 0.18330000 |
| 120 | PASK | 0.18242931 |
| 121 | VRK1 | 0.17701086 |
| 122 | RAF1 | 0.17609506 |
| 123 | PRKACG | 0.17301850 |
| 124 | FYN | 0.16627669 |
| 125 | RPS6KC1 | 0.15836844 |
| 126 | RPS6KL1 | 0.15836844 |
| 127 | JAK2 | 0.13888257 |
| 128 | ZAP70 | 0.13836751 |
| 129 | RPS6KB1 | 0.11829923 |
| 130 | PRKCD | 0.11631182 |
| 131 | PRKCB | 0.10184003 |
| 132 | RPS6KA6 | 0.09661589 |
| 133 | CASK | 0.08393230 |
| 134 | MAP4K1 | 0.08034917 |
| 135 | IGF1R | 0.06626613 |
| 136 | CDK9 | 0.05431387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.64408685 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.54562091 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.85784999 |
| 4 | Mineral absorption_Homo sapiens_hsa04978 | 3.29560464 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.10908868 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.73611507 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.53331715 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.50216784 |
| 9 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.40858939 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.29160475 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 2.26933220 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.91415496 |
| 13 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.91372632 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.90904517 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.87368214 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.86470400 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85244868 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.84149542 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.82382402 |
| 20 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.77974535 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.75527041 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69537162 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62094897 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.54606226 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.53325514 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.53205659 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52869988 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48390226 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46443308 |
| 30 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.45402512 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.34525211 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.32346899 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31429768 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.28905111 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28671986 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.24218657 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.23686207 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23018891 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.19988230 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18787185 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.18196319 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15153088 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12044622 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.09234452 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.09167253 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03364095 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00773384 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98714894 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97867247 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94764950 |
| 51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.94590207 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91429054 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 0.89872490 |
| 54 | Tight junction_Homo sapiens_hsa04530 | 0.86638095 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85961940 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84209462 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73741660 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68835316 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68173429 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67625854 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63696943 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62446110 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60787455 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60450712 |
| 65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.60306091 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60197862 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59224912 |
| 68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.51077948 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.50777337 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50725831 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50300712 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48828390 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.47965606 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47141142 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44489719 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.43800454 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43644614 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43612499 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43223011 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41893495 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39684614 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.37380848 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36873019 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34739723 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.34596177 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.30472012 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30161201 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.29784622 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29695328 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28305793 |
| 91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.25814142 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.24704688 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24268397 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23878054 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.23310104 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22526219 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.21812330 |
| 98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.18173055 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.16543743 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.15153945 |
| 101 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.14959858 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.14945921 |
| 103 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.14798495 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.13732940 |
| 105 | Allograft rejection_Homo sapiens_hsa05330 | 0.12485134 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.11630233 |
| 107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.11354528 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.10822036 |
| 109 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.10528314 |
| 110 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10072671 |
| 111 | Leishmaniasis_Homo sapiens_hsa05140 | 0.09648115 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.08712698 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.08092096 |
| 114 | Influenza A_Homo sapiens_hsa05164 | 0.07929739 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.07825865 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.07354834 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.06634844 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.05340210 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.04714339 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.04270520 |
| 121 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.04012769 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.01093269 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0480709 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | -0.0414869 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0300686 |
| 126 | Type I diabetes mellitus_Homo sapiens_hsa04940 | -0.0215624 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | -0.0147059 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0072007 |

